Immunomodulatory Effects of Hemagglutinin- (HA-) Modified A20 B-Cell Lymphoma Expanded as a Brain Tumor on Adoptively Transferred HA-Specific CD4(+) T Cells

Previously, the mouse A20 B-cell lymphoma engineered to express hemagglutinin (HA) antigen (A20HA) was used as a systemic tumor model. In this work, we used the A20HA cells as a brain tumor. HA-specific CD4(+) T cells were transferred intravenously in a tail vein 5 days after A20HA intracranial inoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shichkin, Valentin P., Moriev, Roman M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947776/
https://www.ncbi.nlm.nih.gov/pubmed/24693228
http://dx.doi.org/10.1155/2014/165265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947776/
https://www.ncbi.nlm.nih.gov/pubmed/24693228
http://dx.doi.org/10.1155/2014/165265

Ejemplares similares